Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies
if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the
same subfield and year (this is the minimum needed to enter the top 1%, not the average
within it), or reaches the top citation threshold in at least one of its specific research
topics.
Infliximab and Methotrexate in the Treatment of Rheumatoid Arthritis
20002.4k citationsMarc Feldmann, Ravinder N. Maini et al.profile →
ROLE OF CYTOKINES IN RHEUMATOID ARTHRITIS
19962.1k citationsMarc Feldmann, Fionula M. Brennan et al.profile →
Infliximab (chimeric anti-tumour necrosis factor α monoclonal antibody) versus placebo in rheumatoid arthritis patients receiving concomitant methotrexate: a randomised phase III trial
19991.9k citationsRavinder N. Maini, Marc Feldmann et al.The Lancetprofile →
Randomised double-blind comparison of chimeric monoclonal antibody to tumour necrosis factor α (cA2) versus placebo in rheumatoid arthritis
19941.3k citationsMichael J. Elliott, Ravinder N. Maini et al.The Lancetprofile →
Therapeutic efficacy of multiple intravenous infusions of anti-tumor necrosis factor ? monoclonal antibody combined with low-dose weekly methotrexate in rheumatoid arthritis
19981.3k citationsRavinder N. Maini, Michael J. Elliott et al.Arthritis & Rheumatismprofile →
IRF5 promotes inflammatory macrophage polarization and TH1-TH17 responses
20111.0k citationsTracy Hussell, Marc Feldmann et al.profile →
Anti-TNFα Therapy of Rheumatoid Arthritis: What Have We Learned?
20011.0k citationsMarc Feldmann, Ravinder N. Mainiprofile →
ROLE OF ABERRANT HLA-DR EXPRESSION AND ANTIGEN PRESENTATION IN INDUCTION OF ENDOCRINE AUTOIMMUNITY
19831.0k citationsMarc Feldmann et al.The Lancetprofile →
Rheumatoid Arthritis
1996880 citationsMarc Feldmann, Fionula M. Brennan et al.profile →
Treatment of rheumatoid arthritis with chimeric monoclonal antibodies to tumor necrosis factor α
1993849 citationsMichael J. Elliott, Ravinder N. Maini et al.Arthritis & Rheumatismprofile →
Anti-tumor necrosis factor ameliorates joint disease in murine collagen-induced arthritis.
1992833 citationsRichard Williams, Marc Feldmann et al.Proceedings of the National Academy of Sciencesprofile →
Excessive production of interleukin 6/B cell stimulatory factor‐2 in rheumatoid arthritis
1988679 citationsMartin Turner, Marc Feldmann et al.European Journal of Immunologyprofile →
Role of interleukin‐1β in postoperative cognitive dysfunction
2010599 citationsNiccolò Terrando, Claudia Monaco et al.profile →
This map shows the geographic impact of Marc Feldmann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marc Feldmann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marc Feldmann more than expected).
This network shows the impact of papers produced by Marc Feldmann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marc Feldmann. The network helps show where Marc Feldmann may publish in the future.
Co-authorship network of co-authors of Marc Feldmann
This figure shows the co-authorship network connecting the top 25 collaborators of Marc Feldmann.
A scholar is included among the top collaborators of Marc Feldmann based on the total number of
citations received by their joint publications. Widths of edges
represent the number of papers authors have co-authored together.
Node borders
signify the number of papers an author published with Marc Feldmann. Marc Feldmann is excluded from
the visualization to improve readability, since they are connected to all nodes in the network.
Feldmann, Marc, et al.. (2010). Schutz von Fahrzeuginsassen durch verbesserte Wirkung von Stahlschutzplanken. RWTH Publications (RWTH Aachen). 54(7).1 indexed citations
5.
Terrando, Niccolò, Claudia Monaco, Brian M. J. Foxwell, Marc Feldmann, & Mervyn Maze. (2010). Tumor necrosis factor-alpha (TNF) triggers a cytokine cascade yielding postoperative cognitive decline. Immunology. 131. 36–36.2 indexed citations
Kiriakidis, Serafim, Evangelos Andreakos, C Monaco, et al.. (2002). VEGF EXPRESSION IN HUMAN MACROPHAGES IS NF kappa B-DEPENDENT: STUDIES USING ADENOVIRUSES EXPRESSING A KINASE DEFECTIVE FORM OF IKK2 or I kappa B alpha THE NATURAL NF kappa B INHIBITOR. Lara D. Veeken. 41. 66–66.1 indexed citations
10.
Durum, Scott K., et al.. (2001). Cytokine reference : a compendium of cytokines and other mediators of host defence. Academic Press eBooks.125 indexed citations
11.
Taylor, Peter C., et al.. (1998). Reduced synovial vascularity following TNF alpha blockade in rheumatoid arthritis.. Arthritis & Rheumatism. 41.2 indexed citations
Elliott, Michael J., et al.. (1994). Repeated therapy with monoclonal antibody to tumour necrosis factor α (cA2) in patients with rheumatoid arthritis. The Lancet. 344(8930). 1125–1127.521 indexed citations breakdown →
Feldmann, Marc, et al.. (1988). Interleukin-2 can prevent and reverse antigen-induced unresponsiveness in cloned human T lymphocytes.. PubMed Central. 64(3). 413–7.125 indexed citations
20.
Erb, Peter, et al.. (1978). Cellular basis of the humoral immune response in mouse and hamster.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 37(7). 2032–4.3 indexed citations
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive
bibliographic database. While OpenAlex provides broad and valuable coverage of the global
research landscape, it—like all bibliographic datasets—has inherent limitations. These include
incomplete records, variations in author disambiguation, differences in journal indexing, and
delays in data updates. As a result, some metrics and network relationships displayed in
Rankless may not fully capture the entirety of a scholar's output or impact.